

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | activation of MAPKKK activity (GO:0000185) | 8.11192784 |
| 2 | purine deoxyribonucleotide catabolic process (GO:0009155) | 6.93657911 |
| 3 | rRNA transcription (GO:0009303) | 5.87147280 |
| 4 | leukocyte aggregation (GO:0070486) | 5.77590798 |
| 5 | nucleoside diphosphate catabolic process (GO:0009134) | 5.48674006 |
| 6 | positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517) | 5.48530060 |
| 7 | intraciliary transport (GO:0042073) | 5.06179392 |
| 8 | signal peptide processing (GO:0006465) | 4.96328922 |
| 9 | deoxyribonucleotide catabolic process (GO:0009264) | 4.95938253 |
| 10 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 4.92402813 |
| 11 | regulation of cilium movement (GO:0003352) | 4.68904684 |
| 12 | piRNA metabolic process (GO:0034587) | 4.59840135 |
| 13 | deoxyribose phosphate catabolic process (GO:0046386) | 4.54121042 |
| 14 | microtubule depolymerization (GO:0007019) | 4.52952278 |
| 15 | positive regulation of signal transduction by p53 class mediator (GO:1901798) | 4.37669581 |
| 16 | immunoglobulin mediated immune response (GO:0016064) | 4.09722845 |
| 17 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 4.08286147 |
| 18 | chaperone-mediated protein transport (GO:0072321) | 4.04664896 |
| 19 | meiotic chromosome segregation (GO:0045132) | 4.00545629 |
| 20 | macroautophagy (GO:0016236) | 3.95679099 |
| 21 | protein maturation by protein folding (GO:0022417) | 3.87424190 |
| 22 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.86295448 |
| 23 | NADH dehydrogenase complex assembly (GO:0010257) | 3.86295448 |
| 24 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.86295448 |
| 25 | ER overload response (GO:0006983) | 3.79993193 |
| 26 | protein complex biogenesis (GO:0070271) | 3.78618809 |
| 27 | ribonucleoprotein complex disassembly (GO:0032988) | 3.77681206 |
| 28 | positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968) | 3.76785050 |
| 29 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146) | 3.76693057 |
| 30 | glucosamine-containing compound catabolic process (GO:1901072) | 3.73155296 |
| 31 | respiratory chain complex IV assembly (GO:0008535) | 3.67472451 |
| 32 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.64105091 |
| 33 | glycoprotein catabolic process (GO:0006516) | 3.58890897 |
| 34 | proteasome assembly (GO:0043248) | 3.58608810 |
| 35 | organelle disassembly (GO:1903008) | 3.58534670 |
| 36 | nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423) | 3.58024864 |
| 37 | GTP biosynthetic process (GO:0006183) | 3.56723410 |
| 38 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.44103226 |
| 39 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.39797328 |
| 40 | autophagic vacuole assembly (GO:0000045) | 3.39730020 |
| 41 | DNA damage response, detection of DNA damage (GO:0042769) | 3.34855491 |
| 42 | DNA methylation involved in gamete generation (GO:0043046) | 3.34353093 |
| 43 | epithelial cilium movement (GO:0003351) | 3.33834156 |
| 44 | purine deoxyribonucleotide metabolic process (GO:0009151) | 3.32760669 |
| 45 | cytochrome complex assembly (GO:0017004) | 3.32474401 |
| 46 | positive regulation of defense response to virus by host (GO:0002230) | 3.32213735 |
| 47 | cilium movement (GO:0003341) | 3.31812505 |
| 48 | I-kappaB kinase/NF-kappaB signaling (GO:0007249) | 3.31790707 |
| 49 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 3.30562293 |
| 50 | sulfate transport (GO:0008272) | 3.27237176 |
| 51 | ubiquinone biosynthetic process (GO:0006744) | 3.26876847 |
| 52 | quinone biosynthetic process (GO:1901663) | 3.26876847 |
| 53 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 3.25172195 |
| 54 | histone H3-K4 trimethylation (GO:0080182) | 3.25158392 |
| 55 | resolution of meiotic recombination intermediates (GO:0000712) | 3.24432643 |
| 56 | mannosylation (GO:0097502) | 3.22403806 |
| 57 | protein polyglutamylation (GO:0018095) | 3.21579493 |
| 58 | ubiquinone metabolic process (GO:0006743) | 3.19929326 |
| 59 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.19607073 |
| 60 | DNA deamination (GO:0045006) | 3.17950270 |
| 61 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.17113938 |
| 62 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.13266053 |
| 63 | mitotic metaphase plate congression (GO:0007080) | 3.10420751 |
| 64 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.09403201 |
| 65 | cellular protein complex localization (GO:0034629) | 3.09205788 |
| 66 | tRNA methylation (GO:0030488) | 3.08786373 |
| 67 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.06293935 |
| 68 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 3.06178094 |
| 69 | positive regulation of mitochondrial fission (GO:0090141) | 3.05912500 |
| 70 | establishment of viral latency (GO:0019043) | 3.04033340 |
| 71 | glycosphingolipid catabolic process (GO:0046479) | 3.02302350 |
| 72 | nucleoside diphosphate phosphorylation (GO:0006165) | 3.02207937 |
| 73 | CTP biosynthetic process (GO:0006241) | 2.99859185 |
| 74 | CTP metabolic process (GO:0046036) | 2.99859185 |
| 75 | axoneme assembly (GO:0035082) | 2.99532040 |
| 76 | COPI coating of Golgi vesicle (GO:0048205) | 2.99467919 |
| 77 | Golgi transport vesicle coating (GO:0048200) | 2.99467919 |
| 78 | formation of translation preinitiation complex (GO:0001731) | 2.98866517 |
| 79 | amino sugar catabolic process (GO:0046348) | 2.97955644 |
| 80 | endothelial cell development (GO:0001885) | 2.97763379 |
| 81 | regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516) | 2.96882607 |
| 82 | B cell mediated immunity (GO:0019724) | 2.95751174 |
| 83 | negative regulation of dendrite development (GO:2000171) | 2.94752626 |
| 84 | nucleotide transmembrane transport (GO:1901679) | 2.94693581 |
| 85 | negative regulation of macroautophagy (GO:0016242) | 2.94536568 |
| 86 | axonemal dynein complex assembly (GO:0070286) | 2.94292159 |
| 87 | regulation of microtubule-based movement (GO:0060632) | 2.93583038 |
| 88 | regulation of mast cell activation (GO:0033003) | 2.93559543 |
| 89 | glycolipid catabolic process (GO:0019377) | 2.92145011 |
| 90 | UTP biosynthetic process (GO:0006228) | 2.91043676 |
| 91 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.90946708 |
| 92 | virion attachment to host cell (GO:0019062) | 2.87688171 |
| 93 | adhesion of symbiont to host cell (GO:0044650) | 2.87688171 |
| 94 | ncRNA catabolic process (GO:0034661) | 2.87655005 |
| 95 | termination of RNA polymerase III transcription (GO:0006386) | 2.86641690 |
| 96 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.86641690 |
| 97 | cytoplasmic pattern recognition receptor signaling pathway (GO:0002753) | 2.85891789 |
| 98 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.84392108 |
| 99 | protein deneddylation (GO:0000338) | 2.84082425 |
| 100 | microtubule polymerization or depolymerization (GO:0031109) | 2.83674274 |
| 101 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.83077712 |
| 102 | regulation of double-strand break repair (GO:2000779) | 2.82733246 |
| 103 | UTP metabolic process (GO:0046051) | 2.82546358 |
| 104 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.82068210 |
| 105 | amyloid precursor protein catabolic process (GO:0042987) | 2.81842697 |
| 106 | positive regulation of viral transcription (GO:0050434) | 2.81061646 |
| 107 | protein targeting to plasma membrane (GO:0072661) | 2.80751172 |
| 108 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.80061793 |
| 109 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.79790229 |
| 110 | regulation of transcription elongation from RNA polymerase II promoter (GO:0034243) | 2.78026181 |
| 111 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.77054352 |
| 112 | GDP-mannose metabolic process (GO:0019673) | 2.77000894 |
| 113 | tRNA processing (GO:0008033) | 2.76521809 |
| 114 | deoxyribose phosphate metabolic process (GO:0019692) | 2.75682732 |
| 115 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.75172253 |
| 116 | regulation of mitochondrial translation (GO:0070129) | 2.73633691 |
| 117 | deoxyribonucleoside diphosphate metabolic process (GO:0009186) | 2.72332073 |
| 118 | cullin deneddylation (GO:0010388) | 2.72076782 |
| 119 | protein peptidyl-prolyl isomerization (GO:0000413) | 2.71966740 |
| 120 | myelin assembly (GO:0032288) | 2.71572652 |
| 121 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.70326751 |
| 122 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.70326751 |
| 123 | regulation of monocyte chemotaxis (GO:0090025) | 2.69280105 |
| 124 | protein localization to cilium (GO:0061512) | 2.68847558 |
| 125 | cell differentiation involved in metanephros development (GO:0072202) | 2.68153710 |
| 126 | pseudouridine synthesis (GO:0001522) | 2.67112765 |
| 127 | induction of positive chemotaxis (GO:0050930) | 2.66556181 |
| 128 | regulation of autophagic vacuole assembly (GO:2000785) | 2.66164193 |
| 129 | protein neddylation (GO:0045116) | 2.64956250 |
| 130 | establishment of endothelial barrier (GO:0061028) | 2.64598609 |
| 131 | positive regulation of action potential (GO:0045760) | 2.64409761 |
| 132 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.63796329 |
| 133 | rRNA modification (GO:0000154) | 2.63660465 |
| 134 | positive regulation of Rho protein signal transduction (GO:0035025) | 2.63110924 |
| 135 | membrane budding (GO:0006900) | 2.61412708 |
| 136 | UV protection (GO:0009650) | 2.61291692 |
| 137 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.59881493 |
| 138 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.59768215 |
| 139 | negative regulation of ligase activity (GO:0051352) | 2.59768215 |
| 140 | apoptotic DNA fragmentation (GO:0006309) | 2.59621374 |
| 141 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.59312067 |
| 142 | cilium assembly (GO:0042384) | 2.58572194 |
| 143 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 2.57870845 |
| 144 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 2.57870845 |
| 145 | polyamine biosynthetic process (GO:0006596) | 2.57596695 |
| 146 | negative regulation of transcription by competitive promoter binding (GO:0010944) | 2.56776026 |
| 147 | regulation of defense response to virus by host (GO:0050691) | 2.56679317 |
| 148 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.56519383 |
| 149 | pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209) | 2.55484995 |
| 150 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.54970105 |
| 151 | ATP synthesis coupled proton transport (GO:0015986) | 2.54291476 |
| 152 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.54291476 |
| 153 | magnesium ion transport (GO:0015693) | 2.54234063 |
| 154 | protein retention in ER lumen (GO:0006621) | 2.52873024 |
| 155 | deoxyribonucleotide metabolic process (GO:0009262) | 2.52453423 |
| 156 | RNA methylation (GO:0001510) | 2.52202552 |
| 157 | tRNA modification (GO:0006400) | 2.51986886 |
| 158 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.51879783 |
| 159 | middle ear morphogenesis (GO:0042474) | 2.51434747 |
| 160 | pyrimidine ribonucleoside triphosphate metabolic process (GO:0009208) | 2.51334425 |
| 161 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 2.50469592 |
| 162 | protein import into peroxisome matrix (GO:0016558) | 2.50163042 |
| 163 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.49794479 |
| 164 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.49300910 |
| 165 | cilium organization (GO:0044782) | 2.49213023 |
| 166 | 7-methylguanosine RNA capping (GO:0009452) | 2.47553580 |
| 167 | RNA capping (GO:0036260) | 2.47553580 |
| 168 | rRNA methylation (GO:0031167) | 2.46587482 |
| 169 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.45957081 |
| 170 | negative regulation of cell killing (GO:0031342) | 2.45957081 |
| 171 | behavioral response to nicotine (GO:0035095) | 2.45929726 |
| 172 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.45372949 |
| 173 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.44194521 |
| 174 | protein complex localization (GO:0031503) | 2.43698715 |
| 175 | mitotic chromosome condensation (GO:0007076) | 2.43425604 |
| 176 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.43171472 |
| 177 | purine nucleotide salvage (GO:0032261) | 2.42716411 |
| 178 | 7-methylguanosine mRNA capping (GO:0006370) | 2.41639272 |
| 179 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.40535938 |
| 180 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.40406088 |
| 181 | cytokinetic process (GO:0032506) | 2.40361673 |
| 182 | regulation of monocyte differentiation (GO:0045655) | 2.39627661 |
| 183 | DNA strand elongation (GO:0022616) | 2.37326709 |
| 184 | metaphase plate congression (GO:0051310) | 2.37258268 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.63075150 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.72686965 |
| 3 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 4.69903492 |
| 4 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.66715878 |
| 5 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.43829759 |
| 6 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.41243359 |
| 7 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.37261151 |
| 8 | * KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.23594386 |
| 9 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.79497525 |
| 10 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.76744231 |
| 11 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.56033050 |
| 12 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.53960909 |
| 13 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.53340512 |
| 14 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.44980889 |
| 15 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.42129233 |
| 16 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.41294799 |
| 17 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.29569532 |
| 18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.24117959 |
| 19 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.16148967 |
| 20 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.10086154 |
| 21 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.09346246 |
| 22 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.05856295 |
| 23 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.05664771 |
| 24 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.05487551 |
| 25 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.05252372 |
| 26 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.03805561 |
| 27 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.00191136 |
| 28 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.95136100 |
| 29 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.92294342 |
| 30 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.91026601 |
| 31 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.88555710 |
| 32 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.85670462 |
| 33 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.84862004 |
| 34 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.80662948 |
| 35 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.78711447 |
| 36 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.76755107 |
| 37 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.76743946 |
| 38 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.73526389 |
| 39 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72837686 |
| 40 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.72356379 |
| 41 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.62076487 |
| 42 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.61885410 |
| 43 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61826081 |
| 44 | VDR_22108803_ChIP-Seq_LS180_Human | 1.60570894 |
| 45 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.60220001 |
| 46 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.59760734 |
| 47 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.57773897 |
| 48 | * CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.55144769 |
| 49 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.53945178 |
| 50 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.48711576 |
| 51 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.40369338 |
| 52 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.37961091 |
| 53 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.37942954 |
| 54 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.37172504 |
| 55 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.36290916 |
| 56 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.35855889 |
| 57 | P300_19829295_ChIP-Seq_ESCs_Human | 1.34126125 |
| 58 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.32276033 |
| 59 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.31601999 |
| 60 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.31445939 |
| 61 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.26114947 |
| 62 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.25650108 |
| 63 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.25434034 |
| 64 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.24634204 |
| 65 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.24184919 |
| 66 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.23357104 |
| 67 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22845730 |
| 68 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.22408906 |
| 69 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.22262333 |
| 70 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.22256498 |
| 71 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.21065791 |
| 72 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.20977444 |
| 73 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.20141989 |
| 74 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.19072169 |
| 75 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.18596664 |
| 76 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.18456861 |
| 77 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.16128806 |
| 78 | * CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.15593035 |
| 79 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15547010 |
| 80 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.15474174 |
| 81 | * SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.13771461 |
| 82 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.13707433 |
| 83 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.12756129 |
| 84 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.12530200 |
| 85 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.11989660 |
| 86 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.11316249 |
| 87 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.11304752 |
| 88 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.11248348 |
| 89 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.10896749 |
| 90 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.10650110 |
| 91 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.09776879 |
| 92 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.09327752 |
| 93 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.09115351 |
| 94 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.07698359 |
| 95 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.07316437 |
| 96 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07307809 |
| 97 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.06555051 |
| 98 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.06274569 |
| 99 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.05608646 |
| 100 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.05496088 |
| 101 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.04864861 |
| 102 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.03940831 |
| 103 | * VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.03619706 |
| 104 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.02939176 |
| 105 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.02524088 |
| 106 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02216146 |
| 107 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01649192 |
| 108 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.00027681 |
| 109 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.98987884 |
| 110 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.98476275 |
| 111 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.98379944 |
| 112 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.97743507 |
| 113 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.97651174 |
| 114 | MYC_22102868_ChIP-Seq_BL_Human | 0.97488152 |
| 115 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.97211358 |
| 116 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.96904434 |
| 117 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.96843210 |
| 118 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96790453 |
| 119 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.96570226 |
| 120 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.96175041 |
| 121 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.93699132 |
| 122 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.93308579 |
| 123 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.92922751 |
| 124 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.92181699 |
| 125 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.92027941 |
| 126 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.91654193 |
| 127 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.91555902 |
| 128 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.91454432 |
| 129 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.91412666 |
| 130 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.91357620 |
| 131 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.91284895 |
| 132 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.91235075 |
| 133 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.90793402 |
| 134 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.90787768 |
| 135 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.90495398 |
| 136 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.90152828 |
| 137 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.89891107 |
| 138 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.89861223 |
| 139 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.89430980 |
| 140 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.89286770 |
| 141 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89183894 |
| 142 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.88228852 |
| 143 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.87978455 |
| 144 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.87928352 |
| 145 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.87882162 |
| 146 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.87727826 |
| 147 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.87455507 |
| 148 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.86558825 |
| 149 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.86371289 |
| 150 | GATA3_26560356_Chip-Seq_TH2_Human | 0.86370443 |
| 151 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.86330999 |
| 152 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.86031366 |
| 153 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.85656635 |
| 154 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.85287220 |
| 155 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.85222736 |
| 156 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.84931285 |
| 157 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.84881626 |
| 158 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.84859850 |
| 159 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.84542906 |
| 160 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.84271820 |
| 161 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.84234994 |
| 162 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.84210163 |
| 163 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.83973449 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005451_abnormal_body_composition | 7.05651999 |
| 2 | MP0005623_abnormal_meninges_morphology | 4.80445274 |
| 3 | MP0001188_hyperpigmentation | 3.31765213 |
| 4 | MP0003880_abnormal_central_pattern | 3.21767710 |
| 5 | MP0006276_abnormal_autonomic_nervous | 3.10243361 |
| 6 | MP0005058_abnormal_lysosome_morphology | 3.00589787 |
| 7 | MP0010386_abnormal_urinary_bladder | 2.96457514 |
| 8 | MP0003786_premature_aging | 2.95549062 |
| 9 | MP0002736_abnormal_nociception_after | 2.94686606 |
| 10 | MP0001968_abnormal_touch/_nociception | 2.90048973 |
| 11 | MP0005645_abnormal_hypothalamus_physiol | 2.70265005 |
| 12 | MP0003806_abnormal_nucleotide_metabolis | 2.67120705 |
| 13 | MP0005083_abnormal_biliary_tract | 2.61387684 |
| 14 | MP0002735_abnormal_chemical_nociception | 2.51968208 |
| 15 | MP0002837_dystrophic_cardiac_calcinosis | 2.46638672 |
| 16 | MP0009840_abnormal_foam_cell | 2.37338468 |
| 17 | MP0002638_abnormal_pupillary_reflex | 2.36656162 |
| 18 | MP0000750_abnormal_muscle_regeneration | 2.26761127 |
| 19 | MP0005646_abnormal_pituitary_gland | 2.26387770 |
| 20 | MP0004947_skin_inflammation | 2.26325261 |
| 21 | MP0005084_abnormal_gallbladder_morpholo | 2.17715628 |
| 22 | MP0008875_abnormal_xenobiotic_pharmacok | 2.08555714 |
| 23 | MP0000015_abnormal_ear_pigmentation | 2.01261855 |
| 24 | MP0009764_decreased_sensitivity_to | 1.95494912 |
| 25 | MP0002148_abnormal_hypersensitivity_rea | 1.94898382 |
| 26 | MP0003123_paternal_imprinting | 1.93536807 |
| 27 | MP0002163_abnormal_gland_morphology | 1.93520888 |
| 28 | MP0002876_abnormal_thyroid_physiology | 1.89681182 |
| 29 | MP0009384_cardiac_valve_regurgitation | 1.89595757 |
| 30 | MP0000858_altered_metastatic_potential | 1.84945483 |
| 31 | MP0006292_abnormal_olfactory_placode | 1.83494207 |
| 32 | MP0000343_altered_response_to | 1.80841602 |
| 33 | MP0008961_abnormal_basal_metabolism | 1.80289495 |
| 34 | MP0005379_endocrine/exocrine_gland_phen | 1.80020035 |
| 35 | MP0001986_abnormal_taste_sensitivity | 1.79343689 |
| 36 | MP0003436_decreased_susceptibility_to | 1.71925528 |
| 37 | MP0003122_maternal_imprinting | 1.71500616 |
| 38 | MP0001835_abnormal_antigen_presentation | 1.68382930 |
| 39 | MP0008260_abnormal_autophagy | 1.68216422 |
| 40 | MP0002693_abnormal_pancreas_physiology | 1.58612422 |
| 41 | MP0003787_abnormal_imprinting | 1.57232537 |
| 42 | MP0002877_abnormal_melanocyte_morpholog | 1.57134810 |
| 43 | MP0004142_abnormal_muscle_tone | 1.55306819 |
| 44 | MP0010307_abnormal_tumor_latency | 1.53838447 |
| 45 | MP0008058_abnormal_DNA_repair | 1.53536391 |
| 46 | MP0002734_abnormal_mechanical_nocicepti | 1.52591867 |
| 47 | MP0005365_abnormal_bile_salt | 1.51153305 |
| 48 | MP0002132_abnormal_respiratory_system | 1.50567235 |
| 49 | MP0001970_abnormal_pain_threshold | 1.50313791 |
| 50 | MP0003638_abnormal_response/metabolism_ | 1.47534512 |
| 51 | MP0002089_abnormal_postnatal_growth/wei | 1.46544486 |
| 52 | MP0003221_abnormal_cardiomyocyte_apopto | 1.45742050 |
| 53 | MP0004134_abnormal_chest_morphology | 1.41400237 |
| 54 | MP0009379_abnormal_foot_pigmentation | 1.40467356 |
| 55 | MP0001502_abnormal_circadian_rhythm | 1.40291846 |
| 56 | MP0004147_increased_porphyrin_level | 1.39973220 |
| 57 | MP0003315_abnormal_perineum_morphology | 1.38818068 |
| 58 | MP0005025_abnormal_response_to | 1.37977131 |
| 59 | MP0002160_abnormal_reproductive_system | 1.37628661 |
| 60 | MP0001270_distended_abdomen | 1.37419650 |
| 61 | MP0001944_abnormal_pancreas_morphology | 1.35886621 |
| 62 | MP0002419_abnormal_innate_immunity | 1.34830535 |
| 63 | MP0004019_abnormal_vitamin_homeostasis | 1.34045255 |
| 64 | MP0004742_abnormal_vestibular_system | 1.34009660 |
| 65 | MP0002452_abnormal_antigen_presenting | 1.33042824 |
| 66 | MP0001529_abnormal_vocalization | 1.32397814 |
| 67 | MP0009250_abnormal_appendicular_skeleto | 1.32150791 |
| 68 | MP0002272_abnormal_nervous_system | 1.32026352 |
| 69 | MP0002909_abnormal_adrenal_gland | 1.30779458 |
| 70 | MP0001664_abnormal_digestion | 1.30696162 |
| 71 | MP0001800_abnormal_humoral_immune | 1.29443781 |
| 72 | MP0008007_abnormal_cellular_replicative | 1.28651429 |
| 73 | MP0001542_abnormal_bone_strength | 1.27101226 |
| 74 | MP0000631_abnormal_neuroendocrine_gland | 1.26911828 |
| 75 | MP0002733_abnormal_thermal_nociception | 1.25660163 |
| 76 | MP0006082_CNS_inflammation | 1.25588431 |
| 77 | MP0001545_abnormal_hematopoietic_system | 1.24078429 |
| 78 | MP0005397_hematopoietic_system_phenotyp | 1.24078429 |
| 79 | MP0002723_abnormal_immune_serum | 1.23949905 |
| 80 | MP0003183_abnormal_peptide_metabolism | 1.23587064 |
| 81 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.23463264 |
| 82 | MP0008873_increased_physiological_sensi | 1.22865787 |
| 83 | MP0003656_abnormal_erythrocyte_physiolo | 1.21889860 |
| 84 | MP0005409_darkened_coat_color | 1.17984902 |
| 85 | MP0002751_abnormal_autonomic_nervous | 1.17108651 |
| 86 | MP0001764_abnormal_homeostasis | 1.16104274 |
| 87 | MP0005000_abnormal_immune_tolerance | 1.15506784 |
| 88 | MP0005671_abnormal_response_to | 1.14840963 |
| 89 | MP0000681_abnormal_thyroid_gland | 1.13744723 |
| 90 | MP0005387_immune_system_phenotype | 1.12998161 |
| 91 | MP0001790_abnormal_immune_system | 1.12998161 |
| 92 | MP0003385_abnormal_body_wall | 1.12016026 |
| 93 | MP0005220_abnormal_exocrine_pancreas | 1.10289577 |
| 94 | MP0002139_abnormal_hepatobiliary_system | 1.09521997 |
| 95 | MP0003136_yellow_coat_color | 1.08386273 |
| 96 | MP0003121_genomic_imprinting | 1.06325057 |
| 97 | MP0001819_abnormal_immune_cell | 1.06288268 |
| 98 | MP0005319_abnormal_enzyme/_coenzyme | 1.06094756 |
| 99 | MP0003186_abnormal_redox_activity | 1.05776190 |
| 100 | MP0005636_abnormal_mineral_homeostasis | 1.04691067 |
| 101 | MP0002067_abnormal_sensory_capabilities | 1.04649038 |
| 102 | MP0002420_abnormal_adaptive_immunity | 1.04586212 |
| 103 | MP0000049_abnormal_middle_ear | 1.04457288 |
| 104 | MP0001501_abnormal_sleep_pattern | 1.04013209 |
| 105 | MP0009765_abnormal_xenobiotic_induced | 1.03821239 |
| 106 | MP0003195_calcinosis | 1.03819261 |
| 107 | MP0002933_joint_inflammation | 1.02950080 |
| 108 | MP0002938_white_spotting | 1.01754879 |
| 109 | MP0005389_reproductive_system_phenotype | 1.01662276 |
| 110 | MP0006036_abnormal_mitochondrial_physio | 1.01601536 |
| 111 | MP0002572_abnormal_emotion/affect_behav | 1.01568163 |
| 112 | MP0000372_irregular_coat_pigmentation | 1.01363895 |
| 113 | MP0003724_increased_susceptibility_to | 1.01237603 |
| 114 | MP0000313_abnormal_cell_death | 1.01076538 |
| 115 | MP0005464_abnormal_platelet_physiology | 1.01018504 |
| 116 | MP0002184_abnormal_innervation | 0.99749486 |
| 117 | MP0009697_abnormal_copulation | 0.99488274 |
| 118 | MP0010155_abnormal_intestine_physiology | 0.99407753 |
| 119 | MP0000678_abnormal_parathyroid_gland | 0.99020109 |
| 120 | MP0002557_abnormal_social/conspecific_i | 0.98850200 |
| 121 | MP0009785_altered_susceptibility_to | 0.98224826 |
| 122 | MP0005670_abnormal_white_adipose | 0.97713745 |
| 123 | MP0001905_abnormal_dopamine_level | 0.97686170 |
| 124 | MP0002177_abnormal_outer_ear | 0.97581480 |
| 125 | MP0009745_abnormal_behavioral_response | 0.96545154 |
| 126 | MP0005410_abnormal_fertilization | 0.94775657 |
| 127 | MP0010094_abnormal_chromosome_stability | 0.94729753 |
| 128 | MP0000013_abnormal_adipose_tissue | 0.94245157 |
| 129 | MP0003693_abnormal_embryo_hatching | 0.93938069 |
| 130 | MP0008469_abnormal_protein_level | 0.93714023 |
| 131 | MP0001919_abnormal_reproductive_system | 0.92897213 |
| 132 | MP0002078_abnormal_glucose_homeostasis | 0.92286060 |
| 133 | MP0003868_abnormal_feces_composition | 0.90951576 |
| 134 | MP0000716_abnormal_immune_system | 0.90770016 |
| 135 | MP0001666_abnormal_nutrient_absorption | 0.90339567 |
| 136 | MP0005164_abnormal_response_to | 0.89848114 |
| 137 | MP0005448_abnormal_energy_balance | 0.89017398 |
| 138 | MP0009763_increased_sensitivity_to | 0.88900832 |
| 139 | MP0004859_abnormal_synaptic_plasticity | 0.88584081 |
| 140 | MP0003878_abnormal_ear_physiology | 0.88245173 |
| 141 | MP0005377_hearing/vestibular/ear_phenot | 0.88245173 |
| 142 | MP0000566_synostosis | 0.88093343 |
| 143 | MP0000358_abnormal_cell_content/ | 0.87898432 |
| 144 | MP0002019_abnormal_tumor_incidence | 0.87486725 |
| 145 | MP0002429_abnormal_blood_cell | 0.85202185 |
| 146 | MP0001533_abnormal_skeleton_physiology | 0.85080339 |
| 147 | MP0003635_abnormal_synaptic_transmissio | 0.84930115 |
| 148 | MP0001929_abnormal_gametogenesis | 0.84653351 |
| 149 | MP0002277_abnormal_respiratory_mucosa | 0.83983732 |
| 150 | MP0008004_abnormal_stomach_pH | 0.83910810 |
| 151 | MP0000163_abnormal_cartilage_morphology | 0.83770788 |
| 152 | MP0002998_abnormal_bone_remodeling | 0.83729969 |
| 153 | MP0002064_seizures | 0.83652030 |
| 154 | MP0006035_abnormal_mitochondrial_morpho | 0.83141323 |
| 155 | MP0003795_abnormal_bone_structure | 0.82648185 |
| 156 | MP0002063_abnormal_learning/memory/cond | 0.81675792 |
| 157 | MP0004782_abnormal_surfactant_physiolog | 0.80601953 |
| 158 | MP0000685_abnormal_immune_system | 0.80318718 |
| 159 | MP0001727_abnormal_embryo_implantation | 0.78703737 |
| 160 | MP0003942_abnormal_urinary_system | 0.78701642 |
| 161 | MP0004808_abnormal_hematopoietic_stem | 0.78486630 |
| 162 | MP0005535_abnormal_body_temperature | 0.78250300 |
| 163 | MP0000490_abnormal_crypts_of | 0.77554563 |
| 164 | MP0002269_muscular_atrophy | 0.77462525 |
| 165 | MP0005332_abnormal_amino_acid | 0.77031170 |
| 166 | MP0002095_abnormal_skin_pigmentation | 0.75833441 |
| 167 | MP0002234_abnormal_pharynx_morphology | 0.75516978 |
| 168 | MP0003191_abnormal_cellular_cholesterol | 0.75467623 |
| 169 | MP0004043_abnormal_pH_regulation | 0.74928408 |
| 170 | MP0002398_abnormal_bone_marrow | 0.74638017 |
| 171 | MP0002970_abnormal_white_adipose | 0.74606507 |
| 172 | MP0004270_analgesia | 0.74422279 |
| 173 | MP0003111_abnormal_nucleus_morphology | 0.73863256 |
| 174 | MP0003763_abnormal_thymus_physiology | 0.73430829 |
| 175 | MP0009333_abnormal_splenocyte_physiolog | 0.73098415 |
| 176 | MP0003953_abnormal_hormone_level | 0.72624231 |
| 177 | MP0003453_abnormal_keratinocyte_physiol | 0.71769092 |
| 178 | MP0002210_abnormal_sex_determination | 0.71411739 |
| 179 | MP0005174_abnormal_tail_pigmentation | 0.70730826 |
| 180 | MP0009780_abnormal_chondrocyte_physiolo | 0.70143605 |
| 181 | MP0003699_abnormal_female_reproductive | 0.69988236 |
| 182 | MP0003828_pulmonary_edema | 0.69800024 |
| 183 | MP0009278_abnormal_bone_marrow | 0.69463422 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Retinal atrophy (HP:0001105) | 8.26932919 |
| 2 | Fatigue (HP:0012378) | 7.98926923 |
| 3 | Cerebellar dysplasia (HP:0007033) | 7.58764386 |
| 4 | Entropion (HP:0000621) | 5.61948360 |
| 5 | Difficulty climbing stairs (HP:0003551) | 4.69014516 |
| 6 | Buphthalmos (HP:0000557) | 4.58621272 |
| 7 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 4.31609287 |
| 8 | 3-Methylglutaconic aciduria (HP:0003535) | 3.92761374 |
| 9 | Multiple enchondromatosis (HP:0005701) | 3.68278772 |
| 10 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.55791120 |
| 11 | Mitochondrial inheritance (HP:0001427) | 3.37422601 |
| 12 | Acute necrotizing encephalopathy (HP:0006965) | 3.36775711 |
| 13 | Poikiloderma (HP:0001029) | 3.36503431 |
| 14 | Irregular vertebral endplates (HP:0003301) | 3.31471407 |
| 15 | Abnormal protein glycosylation (HP:0012346) | 3.31076757 |
| 16 | Abnormal glycosylation (HP:0012345) | 3.31076757 |
| 17 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.31076757 |
| 18 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.31076757 |
| 19 | Type I transferrin isoform profile (HP:0003642) | 3.28874577 |
| 20 | Abnormality of the vertebral endplates (HP:0005106) | 3.22789009 |
| 21 | Abnormality of lateral ventricle (HP:0030047) | 3.12469340 |
| 22 | Reduced antithrombin III activity (HP:0001976) | 3.11851526 |
| 23 | Hypothermia (HP:0002045) | 3.10658167 |
| 24 | Megalocornea (HP:0000485) | 3.07486999 |
| 25 | Focal motor seizures (HP:0011153) | 3.06435160 |
| 26 | Trismus (HP:0000211) | 3.01913532 |
| 27 | Increased IgM level (HP:0003496) | 3.01493411 |
| 28 | Acute encephalopathy (HP:0006846) | 2.99421859 |
| 29 | Hepatocellular necrosis (HP:0001404) | 2.98938428 |
| 30 | Rhinitis (HP:0012384) | 2.97793879 |
| 31 | True hermaphroditism (HP:0010459) | 2.97220566 |
| 32 | Increased CSF lactate (HP:0002490) | 2.94632362 |
| 33 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.94130901 |
| 34 | Submucous cleft hard palate (HP:0000176) | 2.89197227 |
| 35 | Flat capital femoral epiphysis (HP:0003370) | 2.88369533 |
| 36 | Pancreatic cysts (HP:0001737) | 2.85338798 |
| 37 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.84742002 |
| 38 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.84742002 |
| 39 | Vascular calcification (HP:0004934) | 2.82041573 |
| 40 | Renal Fanconi syndrome (HP:0001994) | 2.82025197 |
| 41 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.81767631 |
| 42 | Pancreatic fibrosis (HP:0100732) | 2.77900514 |
| 43 | Type II lissencephaly (HP:0007260) | 2.77577789 |
| 44 | Hepatic necrosis (HP:0002605) | 2.77449261 |
| 45 | Abnormal ciliary motility (HP:0012262) | 2.76776137 |
| 46 | Conjugated hyperbilirubinemia (HP:0002908) | 2.69729524 |
| 47 | Medial flaring of the eyebrow (HP:0010747) | 2.69575386 |
| 48 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.68864091 |
| 49 | Retinal dysplasia (HP:0007973) | 2.67516712 |
| 50 | Ragged-red muscle fibers (HP:0003200) | 2.64482468 |
| 51 | Progressive macrocephaly (HP:0004481) | 2.62019338 |
| 52 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 2.60520618 |
| 53 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.59504562 |
| 54 | Abolished electroretinogram (ERG) (HP:0000550) | 2.58278528 |
| 55 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.56310740 |
| 56 | Delayed CNS myelination (HP:0002188) | 2.55922632 |
| 57 | Metaphyseal dysplasia (HP:0100255) | 2.54248500 |
| 58 | Premature ovarian failure (HP:0008209) | 2.54210886 |
| 59 | Granulocytopenia (HP:0001913) | 2.51881008 |
| 60 | Severe muscular hypotonia (HP:0006829) | 2.51118403 |
| 61 | Severe global developmental delay (HP:0011344) | 2.51073801 |
| 62 | Irregular epiphyses (HP:0010582) | 2.51046764 |
| 63 | Neonatal hypoglycemia (HP:0001998) | 2.51020251 |
| 64 | Increased serum pyruvate (HP:0003542) | 2.48866773 |
| 65 | Lactic acidosis (HP:0003128) | 2.47828070 |
| 66 | Hyperventilation (HP:0002883) | 2.46181046 |
| 67 | Increased hepatocellular lipid droplets (HP:0006565) | 2.45682850 |
| 68 | Congenital glaucoma (HP:0001087) | 2.45264213 |
| 69 | Disinhibition (HP:0000734) | 2.45096364 |
| 70 | Poor head control (HP:0002421) | 2.43251717 |
| 71 | Mesangial abnormality (HP:0001966) | 2.42415455 |
| 72 | Cardiovascular calcification (HP:0011915) | 2.41869053 |
| 73 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.40508250 |
| 74 | Hypoplasia of the brainstem (HP:0002365) | 2.40508250 |
| 75 | Slow saccadic eye movements (HP:0000514) | 2.30247328 |
| 76 | Nephronophthisis (HP:0000090) | 2.29396229 |
| 77 | Abnormal tarsal ossification (HP:0008369) | 2.28659227 |
| 78 | Eosinophilia (HP:0001880) | 2.28628886 |
| 79 | Lipid accumulation in hepatocytes (HP:0006561) | 2.28054377 |
| 80 | Abnormality of renal resorption (HP:0011038) | 2.27146870 |
| 81 | Abnormality of the pons (HP:0007361) | 2.26612913 |
| 82 | Personality changes (HP:0000751) | 2.24165354 |
| 83 | IgG deficiency (HP:0004315) | 2.23756176 |
| 84 | Occipital encephalocele (HP:0002085) | 2.23686236 |
| 85 | Hypoplasia of the pons (HP:0012110) | 2.23311567 |
| 86 | Optic nerve hypoplasia (HP:0000609) | 2.22127012 |
| 87 | Non-midline cleft lip (HP:0100335) | 2.22041257 |
| 88 | Nephrogenic diabetes insipidus (HP:0009806) | 2.21755549 |
| 89 | Abnormal hair whorl (HP:0010721) | 2.20768764 |
| 90 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.20602863 |
| 91 | Xerostomia (HP:0000217) | 2.20004519 |
| 92 | Intellectual disability, profound (HP:0002187) | 2.17660364 |
| 93 | Brittle hair (HP:0002299) | 2.16850655 |
| 94 | Hyperglycinemia (HP:0002154) | 2.16226432 |
| 95 | Abnormality of DNA repair (HP:0003254) | 2.14957444 |
| 96 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.11967062 |
| 97 | Increased serum lactate (HP:0002151) | 2.09217656 |
| 98 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.08739837 |
| 99 | Abnormality of alanine metabolism (HP:0010916) | 2.08739837 |
| 100 | Hyperalaninemia (HP:0003348) | 2.08739837 |
| 101 | Epiphyseal dysplasia (HP:0002656) | 2.07251501 |
| 102 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.06756999 |
| 103 | Absent/shortened dynein arms (HP:0200106) | 2.06756999 |
| 104 | Generalized hypotonia (HP:0001290) | 2.06200145 |
| 105 | Methylmalonic aciduria (HP:0012120) | 2.04198150 |
| 106 | Abnormality of glycolipid metabolism (HP:0010969) | 2.03794790 |
| 107 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.03794790 |
| 108 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.03794790 |
| 109 | Hypertensive crisis (HP:0100735) | 2.02797680 |
| 110 | Lissencephaly (HP:0001339) | 2.02042104 |
| 111 | Abnormality of dental color (HP:0011073) | 2.01119087 |
| 112 | Neuroendocrine neoplasm (HP:0100634) | 2.00163846 |
| 113 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.98992778 |
| 114 | Exertional dyspnea (HP:0002875) | 1.98052576 |
| 115 | Progressive muscle weakness (HP:0003323) | 1.96567116 |
| 116 | Autoimmune thrombocytopenia (HP:0001973) | 1.95885113 |
| 117 | Poor suck (HP:0002033) | 1.94844985 |
| 118 | Genu varum (HP:0002970) | 1.94252642 |
| 119 | Abnormality of the vitreous humor (HP:0004327) | 1.93863752 |
| 120 | Atonic seizures (HP:0010819) | 1.92461987 |
| 121 | Apathy (HP:0000741) | 1.92083808 |
| 122 | Abnormality of the femoral head (HP:0003368) | 1.90840169 |
| 123 | Opisthotonus (HP:0002179) | 1.89961159 |
| 124 | Vacuolated lymphocytes (HP:0001922) | 1.89688297 |
| 125 | Respiratory failure (HP:0002878) | 1.89605190 |
| 126 | Sensory axonal neuropathy (HP:0003390) | 1.88018227 |
| 127 | Stomach cancer (HP:0012126) | 1.87341972 |
| 128 | Cerebral edema (HP:0002181) | 1.86687778 |
| 129 | Abnormality of the epiphysis of the femoral head (HP:0010574) | 1.86598806 |
| 130 | Congenital, generalized hypertrichosis (HP:0004540) | 1.85446833 |
| 131 | Flared iliac wings (HP:0002869) | 1.85178036 |
| 132 | Abnormality of B cell number (HP:0010975) | 1.84293608 |
| 133 | Carpal bone hypoplasia (HP:0001498) | 1.83647677 |
| 134 | Ectropion (HP:0000656) | 1.83500642 |
| 135 | Pulmonary fibrosis (HP:0002206) | 1.83272098 |
| 136 | Flattened epiphyses (HP:0003071) | 1.82678199 |
| 137 | Pachygyria (HP:0001302) | 1.81316316 |
| 138 | Diminished motivation (HP:0000745) | 1.80349586 |
| 139 | Cortical visual impairment (HP:0100704) | 1.79648725 |
| 140 | Molar tooth sign on MRI (HP:0002419) | 1.79012447 |
| 141 | Abnormality of midbrain morphology (HP:0002418) | 1.79012447 |
| 142 | Combined immunodeficiency (HP:0005387) | 1.78877693 |
| 143 | Chronic bronchitis (HP:0004469) | 1.78179477 |
| 144 | Short tibia (HP:0005736) | 1.77868917 |
| 145 | Congenital primary aphakia (HP:0007707) | 1.76817529 |
| 146 | Hypoglycemic seizures (HP:0002173) | 1.76117409 |
| 147 | Microvesicular hepatic steatosis (HP:0001414) | 1.75983013 |
| 148 | Metaphyseal irregularity (HP:0003025) | 1.74831588 |
| 149 | Abnormality involving the epiphyses of the lower limbs (HP:0006500) | 1.74366755 |
| 150 | Abnormality of femoral epiphyses (HP:0006499) | 1.74366755 |
| 151 | Gait imbalance (HP:0002141) | 1.74307017 |
| 152 | Erythroderma (HP:0001019) | 1.73847612 |
| 153 | Short nail (HP:0001799) | 1.73846283 |
| 154 | Split foot (HP:0001839) | 1.73135342 |
| 155 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.72939062 |
| 156 | Inappropriate behavior (HP:0000719) | 1.72804420 |
| 157 | Small epiphyses (HP:0010585) | 1.70825167 |
| 158 | Cleft eyelid (HP:0000625) | 1.70506199 |
| 159 | Exercise intolerance (HP:0003546) | 1.70172376 |
| 160 | Hyperphosphaturia (HP:0003109) | 1.70138402 |
| 161 | Upper motor neuron abnormality (HP:0002127) | 1.69825170 |
| 162 | Barrel-shaped chest (HP:0001552) | 1.69298744 |
| 163 | Abnormality of the renal medulla (HP:0100957) | 1.68770235 |
| 164 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.68761239 |
| 165 | Decreased subcutaneous fat (HP:0001002) | 1.68590292 |
| 166 | Supranuclear gaze palsy (HP:0000605) | 1.67809347 |
| 167 | Absent eyelashes (HP:0000561) | 1.66879919 |
| 168 | Respiratory difficulties (HP:0002880) | 1.66860328 |
| 169 | Keratitis (HP:0000491) | 1.61528796 |
| 170 | Rough bone trabeculation (HP:0100670) | 1.61268467 |
| 171 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.60715827 |
| 172 | Abnormality of eosinophils (HP:0001879) | 1.60244651 |
| 173 | Male infertility (HP:0003251) | 1.60216216 |
| 174 | Overriding aorta (HP:0002623) | 1.59545826 |
| 175 | Conical tooth (HP:0000698) | 1.57437835 |
| 176 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.56608680 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK10 | 6.21231188 |
| 2 | MARK3 | 4.88609686 |
| 3 | MST4 | 4.86812273 |
| 4 | TLK1 | 3.90628502 |
| 5 | CLK1 | 3.87755260 |
| 6 | STK16 | 3.68185492 |
| 7 | BMPR2 | 3.39849310 |
| 8 | MAP2K7 | 3.10691224 |
| 9 | CASK | 3.07642397 |
| 10 | NTRK3 | 2.86874128 |
| 11 | EIF2AK3 | 2.35132678 |
| 12 | SRPK1 | 2.33022979 |
| 13 | BCKDK | 2.18244044 |
| 14 | ABL2 | 2.11065196 |
| 15 | BLK | 2.09452104 |
| 16 | ZAK | 1.98478959 |
| 17 | MAPK13 | 1.96513685 |
| 18 | TAOK1 | 1.95291785 |
| 19 | IRAK1 | 1.87171612 |
| 20 | TNIK | 1.83452789 |
| 21 | PIM1 | 1.81608253 |
| 22 | FES | 1.79099770 |
| 23 | BMPR1B | 1.78584488 |
| 24 | DYRK2 | 1.71579410 |
| 25 | MAP3K14 | 1.70839458 |
| 26 | AKT3 | 1.64735484 |
| 27 | MAPKAPK3 | 1.57605308 |
| 28 | PRKD3 | 1.55418097 |
| 29 | MUSK | 1.55335141 |
| 30 | IRAK3 | 1.54377342 |
| 31 | BRAF | 1.51271400 |
| 32 | CDK8 | 1.48814529 |
| 33 | VRK1 | 1.46997220 |
| 34 | MAPK15 | 1.46483464 |
| 35 | CDC7 | 1.45530476 |
| 36 | PIM2 | 1.44438627 |
| 37 | DYRK3 | 1.36221567 |
| 38 | MAP3K4 | 1.30793769 |
| 39 | NLK | 1.29695552 |
| 40 | STK38L | 1.29600771 |
| 41 | WNK4 | 1.29537436 |
| 42 | CDK19 | 1.29478777 |
| 43 | MAP3K3 | 1.28017451 |
| 44 | PTK2B | 1.27167477 |
| 45 | ADRBK2 | 1.26769271 |
| 46 | PLK1 | 1.20626485 |
| 47 | YES1 | 1.20594133 |
| 48 | STK11 | 1.20151393 |
| 49 | SIK3 | 1.15399818 |
| 50 | IKBKB | 1.13021104 |
| 51 | PRPF4B | 1.11323288 |
| 52 | EEF2K | 1.10889339 |
| 53 | BRSK2 | 1.09935948 |
| 54 | NME1 | 1.09367050 |
| 55 | EPHA4 | 1.08630001 |
| 56 | IRAK4 | 1.08539515 |
| 57 | WNK3 | 1.08249902 |
| 58 | TTK | 1.05010360 |
| 59 | ERBB2 | 1.04241990 |
| 60 | MATK | 1.03574088 |
| 61 | CSF1R | 1.01837426 |
| 62 | LIMK1 | 1.00793398 |
| 63 | EPHA3 | 0.94588720 |
| 64 | MET | 0.94414065 |
| 65 | TEC | 0.93326459 |
| 66 | PLK4 | 0.92206235 |
| 67 | INSRR | 0.92198690 |
| 68 | AKT2 | 0.91047224 |
| 69 | MAP3K2 | 0.90208388 |
| 70 | EGFR | 0.89755531 |
| 71 | PIK3CG | 0.88053057 |
| 72 | DYRK1A | 0.86100671 |
| 73 | TYK2 | 0.84590683 |
| 74 | MKNK2 | 0.84033009 |
| 75 | TAOK3 | 0.80976770 |
| 76 | GRK6 | 0.80523842 |
| 77 | PRKCI | 0.80459118 |
| 78 | ARAF | 0.77765906 |
| 79 | ERN1 | 0.76400064 |
| 80 | BUB1 | 0.75804864 |
| 81 | TXK | 0.74667493 |
| 82 | KIT | 0.74285794 |
| 83 | CSNK1A1L | 0.71931443 |
| 84 | SCYL2 | 0.71613489 |
| 85 | ZAP70 | 0.70008187 |
| 86 | LMTK2 | 0.69101504 |
| 87 | PRKCE | 0.69099993 |
| 88 | CHEK1 | 0.68937568 |
| 89 | MAPK11 | 0.66864959 |
| 90 | CSNK1G3 | 0.66840168 |
| 91 | WEE1 | 0.66332818 |
| 92 | IRAK2 | 0.65870774 |
| 93 | NME2 | 0.65717168 |
| 94 | MAP3K12 | 0.63321163 |
| 95 | CAMK2B | 0.63228082 |
| 96 | NUAK1 | 0.62195535 |
| 97 | PLK2 | 0.62083083 |
| 98 | CDK11A | 0.61621206 |
| 99 | FRK | 0.61439834 |
| 100 | TBK1 | 0.61017734 |
| 101 | CSNK1G2 | 0.60879658 |
| 102 | CDK9 | 0.60716484 |
| 103 | AURKB | 0.60684185 |
| 104 | AURKA | 0.60514692 |
| 105 | RIPK1 | 0.58886770 |
| 106 | MAP3K5 | 0.58261209 |
| 107 | JAK3 | 0.57551297 |
| 108 | TESK1 | 0.57510540 |
| 109 | PRKCG | 0.57103194 |
| 110 | CDK3 | 0.56942446 |
| 111 | FER | 0.56599610 |
| 112 | MAP3K6 | 0.56595616 |
| 113 | ATR | 0.55589047 |
| 114 | MAP3K13 | 0.54948014 |
| 115 | PASK | 0.54510892 |
| 116 | CDK14 | 0.54018081 |
| 117 | PINK1 | 0.53012331 |
| 118 | CAMK2D | 0.52456544 |
| 119 | CDK15 | 0.51032393 |
| 120 | CDK7 | 0.50819778 |
| 121 | GRK7 | 0.49617696 |
| 122 | PRKD2 | 0.49024312 |
| 123 | MST1R | 0.48375873 |
| 124 | CHUK | 0.48308789 |
| 125 | RPS6KB2 | 0.47746867 |
| 126 | NEK1 | 0.46955243 |
| 127 | UHMK1 | 0.46815399 |
| 128 | MINK1 | 0.46584209 |
| 129 | CAMK2G | 0.45201034 |
| 130 | CDK18 | 0.44966400 |
| 131 | MARK1 | 0.44760610 |
| 132 | MAP3K8 | 0.43491683 |
| 133 | IKBKE | 0.42781570 |
| 134 | BRSK1 | 0.41664517 |
| 135 | BTK | 0.41360334 |
| 136 | CSNK1A1 | 0.41164890 |
| 137 | MAP3K11 | 0.41062343 |
| 138 | PDK2 | 0.40555759 |
| 139 | RPS6KA4 | 0.40157072 |
| 140 | MKNK1 | 0.39590661 |
| 141 | MAPKAPK5 | 0.39357754 |
| 142 | EIF2AK2 | 0.38611700 |
| 143 | CHEK2 | 0.38594073 |
| 144 | EIF2AK1 | 0.38590193 |
| 145 | CSNK2A1 | 0.38403992 |
| 146 | RPS6KB1 | 0.37855579 |
| 147 | EPHA2 | 0.37728893 |
| 148 | CDC42BPA | 0.37688316 |
| 149 | MAP2K2 | 0.37398206 |
| 150 | TESK2 | 0.37197735 |
| 151 | DDR2 | 0.37195741 |
| 152 | TAOK2 | 0.36549301 |
| 153 | MAPK14 | 0.36495572 |
| 154 | SYK | 0.36134144 |
| 155 | LCK | 0.34986952 |
| 156 | CSNK1E | 0.33165847 |
| 157 | PTK2 | 0.32897926 |
| 158 | PRKCQ | 0.31494305 |
| 159 | CSNK2A2 | 0.31349896 |
| 160 | TGFBR1 | 0.30825820 |
| 161 | MAP4K1 | 0.28661200 |
| 162 | RPS6KA2 | 0.27188119 |
| 163 | CDK4 | 0.25927762 |
| 164 | TSSK6 | 0.23851449 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protein export_Homo sapiens_hsa03060 | 5.86594613 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 3.43084657 |
| 3 | Asthma_Homo sapiens_hsa05310 | 3.40567593 |
| 4 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.97019072 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.61710879 |
| 6 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.61518632 |
| 7 | Allograft rejection_Homo sapiens_hsa05330 | 2.48252882 |
| 8 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.42239699 |
| 9 | Leishmaniasis_Homo sapiens_hsa05140 | 2.40671678 |
| 10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.39004047 |
| 11 | Parkinsons disease_Homo sapiens_hsa05012 | 2.34821390 |
| 12 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.25086510 |
| 13 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.22445834 |
| 14 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.09783947 |
| 15 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.06301161 |
| 16 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.05108603 |
| 17 | RNA polymerase_Homo sapiens_hsa03020 | 2.04337584 |
| 18 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.01844601 |
| 19 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.01471055 |
| 20 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.98112206 |
| 21 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.97192928 |
| 22 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.89292130 |
| 23 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.88640701 |
| 24 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.80027345 |
| 25 | Sulfur relay system_Homo sapiens_hsa04122 | 1.79552425 |
| 26 | Huntingtons disease_Homo sapiens_hsa05016 | 1.78749268 |
| 27 | Shigellosis_Homo sapiens_hsa05131 | 1.78261507 |
| 28 | Viral myocarditis_Homo sapiens_hsa05416 | 1.77374319 |
| 29 | DNA replication_Homo sapiens_hsa03030 | 1.76964254 |
| 30 | Alzheimers disease_Homo sapiens_hsa05010 | 1.75314106 |
| 31 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.73351789 |
| 32 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.70250543 |
| 33 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.69759251 |
| 34 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.67552707 |
| 35 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.65452105 |
| 36 | * SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.63908663 |
| 37 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.61686632 |
| 38 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.47160392 |
| 39 | Ribosome_Homo sapiens_hsa03010 | 1.46596032 |
| 40 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.45835542 |
| 41 | Other glycan degradation_Homo sapiens_hsa00511 | 1.45544605 |
| 42 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.42759038 |
| 43 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.41548268 |
| 44 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.40162375 |
| 45 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.38940039 |
| 46 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.37883740 |
| 47 | Purine metabolism_Homo sapiens_hsa00230 | 1.37675426 |
| 48 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.36552044 |
| 49 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.35041461 |
| 50 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.29098967 |
| 51 | Homologous recombination_Homo sapiens_hsa03440 | 1.29076052 |
| 52 | Basal transcription factors_Homo sapiens_hsa03022 | 1.28825645 |
| 53 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.26574571 |
| 54 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.25547612 |
| 55 | Mismatch repair_Homo sapiens_hsa03430 | 1.24497571 |
| 56 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.23781155 |
| 57 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.19253065 |
| 58 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.14248823 |
| 59 | Tuberculosis_Homo sapiens_hsa05152 | 1.12432373 |
| 60 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.12379663 |
| 61 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.10445001 |
| 62 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.08769453 |
| 63 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.05721823 |
| 64 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.01639732 |
| 65 | Metabolic pathways_Homo sapiens_hsa01100 | 0.99307940 |
| 66 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.96969685 |
| 67 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.96928707 |
| 68 | Nicotine addiction_Homo sapiens_hsa05033 | 0.95931286 |
| 69 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.95427312 |
| 70 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.95282259 |
| 71 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.93709666 |
| 72 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.93703876 |
| 73 | Influenza A_Homo sapiens_hsa05164 | 0.93018801 |
| 74 | Apoptosis_Homo sapiens_hsa04210 | 0.90603108 |
| 75 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.90329784 |
| 76 | Salmonella infection_Homo sapiens_hsa05132 | 0.89010848 |
| 77 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.88619206 |
| 78 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.87357850 |
| 79 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.84360185 |
| 80 | Base excision repair_Homo sapiens_hsa03410 | 0.82470490 |
| 81 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.81305617 |
| 82 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.81067114 |
| 83 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.79221659 |
| 84 | Peroxisome_Homo sapiens_hsa04146 | 0.77693303 |
| 85 | Hepatitis C_Homo sapiens_hsa05160 | 0.71783109 |
| 86 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.69438222 |
| 87 | Circadian rhythm_Homo sapiens_hsa04710 | 0.68867726 |
| 88 | Insulin secretion_Homo sapiens_hsa04911 | 0.67693369 |
| 89 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.65241807 |
| 90 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.65187270 |
| 91 | Hepatitis B_Homo sapiens_hsa05161 | 0.64681901 |
| 92 | Lysosome_Homo sapiens_hsa04142 | 0.63834407 |
| 93 | Histidine metabolism_Homo sapiens_hsa00340 | 0.62089091 |
| 94 | Adherens junction_Homo sapiens_hsa04520 | 0.60844692 |
| 95 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.60323848 |
| 96 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.59604110 |
| 97 | Cocaine addiction_Homo sapiens_hsa05030 | 0.58905150 |
| 98 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.58300328 |
| 99 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.57446894 |
| 100 | Olfactory transduction_Homo sapiens_hsa04740 | 0.57303000 |
| 101 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.56054221 |
| 102 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.55939663 |
| 103 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.55737767 |
| 104 | HTLV-I infection_Homo sapiens_hsa05166 | 0.55144348 |
| 105 | Morphine addiction_Homo sapiens_hsa05032 | 0.55016308 |
| 106 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.53262234 |
| 107 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.53111559 |
| 108 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.52929581 |
| 109 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.52702953 |
| 110 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.52575387 |
| 111 | * Phagosome_Homo sapiens_hsa04145 | 0.52149719 |
| 112 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.51371349 |
| 113 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.51191815 |
| 114 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.50916930 |
| 115 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.49558166 |
| 116 | Spliceosome_Homo sapiens_hsa03040 | 0.49442163 |
| 117 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.49174524 |
| 118 | Tight junction_Homo sapiens_hsa04530 | 0.48759610 |
| 119 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.48724212 |
| 120 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.48630972 |
| 121 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.48530524 |
| 122 | Cell cycle_Homo sapiens_hsa04110 | 0.47654598 |
| 123 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.47412117 |
| 124 | Galactose metabolism_Homo sapiens_hsa00052 | 0.47197574 |
| 125 | Pertussis_Homo sapiens_hsa05133 | 0.46875891 |
| 126 | Bladder cancer_Homo sapiens_hsa05219 | 0.46838086 |
| 127 | Taste transduction_Homo sapiens_hsa04742 | 0.46124793 |
| 128 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.42983378 |
| 129 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.42685857 |
| 130 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.42145611 |
| 131 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.40921815 |
| 132 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.40692011 |
| 133 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.39901017 |
| 134 | Circadian entrainment_Homo sapiens_hsa04713 | 0.39410103 |
| 135 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.39399704 |
| 136 | RNA transport_Homo sapiens_hsa03013 | 0.39336451 |
| 137 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.37687649 |
| 138 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.37678041 |
| 139 | Alcoholism_Homo sapiens_hsa05034 | 0.37598234 |
| 140 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.36906101 |
| 141 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.35304239 |
| 142 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.35286545 |
| 143 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.34879027 |
| 144 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.32316567 |
| 145 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.32048595 |
| 146 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.31930106 |
| 147 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.29158089 |
| 148 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.29116557 |
| 149 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.28180921 |
| 150 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.28080284 |
| 151 | RNA degradation_Homo sapiens_hsa03018 | 0.27903122 |
| 152 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.26186925 |
| 153 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.23151612 |
| 154 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.23045039 |
| 155 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.22902688 |
| 156 | GABAergic synapse_Homo sapiens_hsa04727 | 0.22497520 |

